Trial
NCT04393311
Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
COVID-19
Intervention
Ulinastatin
Why stopped
Discontinuation of drug candidates
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-03